Roche Holding company profile
Secondary listing. The primary listing is Roche Holding · SIX (CHF)
Company profile
Roche Holding has 103,249 employees and is headquartered in Basel, Switzerland.
Based in Basel, Switzerland, Roche Holding AG was founded in 1896 and operates in pharmaceuticals and diagnostics. Its pharma portfolio covers therapeutic areas such as oncology, neurological disorders, ophthalmology, dermatology and transplantation. Its diagnostics business offers in vitro tests for diseases including cancer, diabetes and hepatitis, along with diagnostic instruments and digital health solutions. The group sells in Europe, North America, Latin America, Asia, Africa, Australia and New Zealand.
In the fiscal year ended December 2025, Roche reported revenue of CHF 63.4 billion, up 1.5% from the previous year, and net income of CHF 12.9 billion. The company has 103,249 employees and its headquarters are in Basel. Its shares are also listed on SIX.
Company facts
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- Switzerland
- Headquarters
- Grenzacherstrasse 124, 4070, Basel
- Employees
- 103,249
- Listing
- RO · SIX
- Currency
- CHF
- ISIN
- CH0012032113
- Website
- roche.com
Roche Holding and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Roche HoldingRO | Switzerland | $392.79B | 103,249 | 33.1% | 27.0 |
| NovartisNOVN | Switzerland | $305.16B | 75,267 | 34.0% | 32.6 |
| AstraZenecaAZN | United Kingdom | $287.12B | 96,100 | 25.8% | 26.6 |
| Novo NordiskNOVO.B | Denmark | $184.87B | 68,794 | 50.8% | 11.2 |
| SanofiSAN | France | $116.52B | 74,846 | 22.3% | 25.5 |
| GSKGSK | United Kingdom | $102.04B | 66,841 | 30.5% | 18.0 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
